The Janssen vaccine, a division of the American laboratory Johnson & Johnson, is arriving in France. Who will be able to be vaccinated with this serum administered in a single dose?
Janssen vaccine, for whom?
It was Gabriel Attal, the spokesperson for the French government, who made the announcement this Wednesday, April 14. The Johnson & Johnson vaccine will be ” distributed and administered under the same conditions as currently planned for the AstraZeneca vaccine, i.e. for people over 55 years of age. “Doses have been delivered, as he confirms:” We received the first delivery of vaccines, that is to say 200,000 doses which arrived at the beginning of the week in our territory and which are being sent to the town medicine and pharmacy dispensaries.. ”
France decides to authorize, for the moment, the administration of this vaccine to the population. This is not the case of the United States, since April 13, which wishes to do “ pause And suspend the use of the Johnson & Johnson vaccine. Indeed, several cases of rare and serious blood clots have occurred after an injection with this serum. The pharmaceutical company decided, a few moments later, to delay the deployment of its vaccines in Europe, the time of the health investigation.
